TechImmune is advancing development of a next-generation, broad-spectrum COVID vaccine designed to obviate the necessity for frequent updating and recurrent boosting that characterize existing vaccines. Th firm's innovative strategy targets multiple antigens to elicit a comprehensive immune response, involving both antibody and T cell activation, in contrast to conventional vaccines that utilize the Spike protein to induce neutralizing antibodies. TechImmune's Coronavirus vaccine is described as encompassing a more advanced approach to enhance long-lasting immunity and disrupt the current booster paradigm.
